Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991
Open Access
- 1 December 2000
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 14 (12) , 2240-2246
- https://doi.org/10.1038/sj.leu.2401964
Abstract
Here we report the long-term results of the DCLSG protocols ALL-6 and -7 with special emphasis on the incidence of CNS relapse after treatment without cranial irradiation. In DCLSG protocol ALL-6 (1984–1988), designed for patients with ALL non-high risk (ALL-NHR) (WBC 9/l, no mediastinal mass, no B cell phenotype and no CNS involvement at diagnosis, comprising 71% of all ALL patients), CNS prophylaxis consisted of a combination of three methods of chemotherapeutic CNS prophylaxis (the use of dexamethasone during induction and maintenance therapy, i.v. medium dose methotrexate and prolonged administration of intrathecal triple therapy). Total duration of treatment: 116 weeks. 190 patients were enrolled in the study. At 10 years, the EFS rate for all patients is 81.5 ± 2.8%, the survival rate 84.8 ± 2.7%, and the cumulative incidence of isolated CNS relapse 1.1 ± 0.8%. The 10-year survival rate for the 139/190 (73.1%) patients with standard risk non-T lineage ALL according to the NCI risk criteria is 80.5 ± 3.4%. DCLSG protocol-7 was identical to the intensive ALL-BFM-86 protocol, but cranial irradiation was restricted to patients with initial CNS involvement. Patients were stratified into three risk groups (SRG, RG and EG). Treatment duration was 18 months. 218 patients were enrolled in the study. At 10 years, the EFS rate for all patients is 63.4 ± 3.3%, the survival rate 76.4 ± 3.0%, the 5-year cumulative incidence of isolated CNS relapse 5.7 ± 1.8%. The EFS rate at 10 years of the 127/218 (58.3%) patients with standard risk non-T-lineage ALL according to the NCI risk criteria was 67.9 ± 4.3%, which is not significantly different from the results achieved in this category of patients with the moderately intensive treatment according to protocol ALL-6 (logrank P = 0.17). These DCLSG studies indicate that omission of cranial irradiation does not jeopardize the overall good results.Keywords
This publication has 9 references indexed in Scilit:
- Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.Journal of Clinical Oncology, 1997
- High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.Journal of Clinical Oncology, 1996
- Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.Journal of Clinical Oncology, 1996
- Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86Blood, 1994
- Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM family” cooperative groupMedical and Pediatric Oncology, 1992
- Diagnosis of meningeal involvement in childhood acute lymphoblastic leukemia: Cytomorphology and TdTEuropean Journal of Haematology, 1988
- Abschätzung der Tumorzellmasse bei der akuten lymphoblastischen Leukämie im Kindesalter: prognostische Bedeutung und praktische Anwendung*Klinische Padiatrie, 1982
- The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical CorrelationsBritish Journal of Haematology, 1981
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976